City of Hope is recruiting for 2 junior faculty for GI Oncology (see ALL GI tumors). 1 position for our main campus (Duarte) and 1 for our Irvine campus (Lennar) in beautiful S. California (Los Angeles and Orange County). Please feel free to pass this info over and message me.

Marwan G. Fakih, MD,(Dr. Marwan G. Fakih) discusses the next steps for the clinical development of the balstilimab plus botensilimab in microsatellite stable metastatic colorectal cancer without liver metastases. #crcsm | City of Hope hubs.li/Q03b1J9X0

Center and Fakih provide the 𝘾𝙇𝙄𝙉𝘾𝙃𝙀𝙍, 6-4 on 2 ✅ #GoBruins

Go Kate Fakih! Go BRUINS

Dr. Marwan G. Fakih, of City of Hope and Nilo Azad, MD, of Johns Hopkins Kimmel Cancer Center discuss their preferred treatment options for patients in the third-line setting of mCRC, focusing on regorafenib, trifluridine-tipiracil plus bevacizumab, and fruquintinib. Watch here: hubs.li/Q03bJQlB0

𝗞𝗔𝗧𝗘. 𝗙𝗔𝗞𝗜𝗛. Bruins win 4-3 😤 #GoBruins

𝐁𝟏𝐆-𝐭𝐢𝐦𝐞 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 for the Bruins, who snap Wisconsin's 13-match winning streak 🙌 #GoBruins

No moment too B1G for Kate Fakih. #GoBruins

Another clincher for Fakih, whose 6-0, 6-3 win completes the sweep 🙌 #GoBruins

𝙒𝙚𝙚𝙠𝙚𝙣𝙙 𝙒𝙨 ✅✅ #GoBruins

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… Meaningful clinical benefits for KRAS G12C MCRC!

Nice finish for Kate Fakih and for the UCLA Team- Go Bruins!

The Bruins #BeatSC to extend their winning streak to 6⃣ 🙌 Kate Fakih clinches for the fourth time in five matches. #GoBruins

Go Bruins!! 5th in a row!! Good luck this Fri/Sat-- Rutgers and Maryland are next!

Study Details | FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery | ClinicalTrials.gov NCT06780787 RT-Sparing Neoadj pRectal Ca - FOLFOX + Botenislimab + Balstilimab-- 🙏Gateway Foundation for funding- now at City of Hope!

Results from the phase 3 CodeBreaK trial support the use of 960 mg of sotorasib plus panitumumab as standard of care in metastatic colorectal cancer. #crcsm | Dr. Marwan G. Fakih hubs.li/Q03kLBD50

ICYMI: Watch Marwan Fakih, MD, (Dr. Marwan G. Fakih) of City of Hope discuss the clinical relevance of the FDA’s approval of retifanlimab for patients with squamous cell carcinoma of the anal canal. #oncology #FDAapproved onclive.com/view/dr-fakih-…

It’s Day 1 of #ASCO25! Over the next few days, City of Hope experts — including Saro Armenian Dr. Marwan G. Fakih Sumanta K. Pal, MD, FASCO Hope Rugo Alan H Bryce — will be featured across several key sessions. Explore the highlights and full schedule at CityofHope.org/asco25.

ustasocal.com/news/kate-faki…

Worthy of a plenary session — CO.21 shows that exercise reduces recurrence after adjuvant and improves OS